• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.13% Nasdaq Up 0.70%

    Sucampo Pharmaceuticals, Inc. (SCMP)

    -NasdaqGM
    13.61 Down 0.14(1.02%) Dec 26, 4:00PM EST
    Add to Portfolio
    Prev Close:13.75
    Open:13.75
    Bid:9.05 x 100
    Ask:N/A
    1y Target Est:14.20
    Beta:3.01
    Earnings Date:Feb 24 - Mar 2 (Est.)
    Day's Range:13.49 - 13.99
    52wk Range:5.80 - 14.38
    Volume:135,649
    Avg Vol (3m):245,240
    Market Cap:596.19M
    P/E (ttm):105.50
    EPS (ttm):0.13
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    SCMPDown 1.02%596.19M
    IRWDUp 2.61%2.09B
    PGNXUp 3.58%503.58M
    THRXUp 3.30%1.73B

    Key Statistics

    Forward P/E (1 yr):24.30
    P/S (ttm):6.01
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :0.46
    Quarterly EPS Est (Dec-14) :0.23
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):0.37

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Sucampo Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, discovery, development, and commercialization of proprietary drugs based on prostones and other drug technologies in the Americas, Europe, and Asia. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback